Antony Rosen, M.D., Named Vice Dean for Research

To the Johns Hopkins Medicine community

Dear Colleagues:

We are delighted to announce that Antony Rosen, M.D., the Mary Betty Stevens Professor of Medicine, as well as professor of pathology and chief of the Division of Rheumatology, will become the new vice dean for research. He will assume his new duties Dec. 1. He will also continue to lead the Division of Rheumatology.

In addition to being a creative and effective researcher, clinician and teacher, Antony has been highly successful in recruiting and mentoring the next generation of clinical and translational investigators in the rheumatic diseases. As head of the Division of Rheumatology since 2002, he has fostered a substantial expansion of its fellowship program, increased the size of its faculty from 14 to 28 outstanding individuals, and created several successful, interdisciplinary specialty centers focused on both patient care and scholarship.

Along with his wife, Livia Casciola-Rosen, Ph.D., Antony leads a remarkable, laboratory that focuses on defining the extraordinarily complex mechanisms of human autoimmune rheumatic diseases, including rheumatoid arthritis, myositis, scleroderma, systemic lupus erythematosus (SLE) and Sjögren's syndrome. Their work is highly collaborative with investigators across the breadth of the Institutions, and leverages the important synergies that our environment can offer.

Graduating in 1984 as a first class honors student in the medical school of the University of Cape Town in South Africa, Antony completed his internship in medicine and surgery, as well as a year of postdoctoral study in medical biochemistry, before joining Alan Aderem, Ph.D., at Rockefeller University to undertake postdoctoral studies in immunology and cell biology from 1987 to 1990.

Returning to clinical medicine, Antony was an Osler resident and rheumatology fellow in the Johns Hopkins University School of Medicine. He joined the faculty and became a full professor in 2002.

The leadership qualities of collaboration, creativity and effectiveness that Antony has demonstrated will suit him well as vice dean for research. Ours is an enormous research enterprise. The school of medicine has been among the largest awardees of NIH biomedical funding for years, receiving $436 million in 2012. To maintain and expand our pre-eminence in such research, we need a vice dean of exceptional abilities—like Antony.

Antony will succeed Landon S. King, M.D., the David Marine Professor of Medicine and Biological Chemistry and head of the Division of Pulmonary and Critical Care Medicine. Landon has been serving as both vice dean for research, a role he has had since September 2011, and as executive vice dean since December 2012. He will remain as executive vice dean, a position in which he has been doing a splendid job assisting in the oversight of operations and program development in the school of medicine.

We are pleased to have Antony join our executive team as vice dean for research and look forward to working with him and all our team members to advance this vital area of Johns Hopkins Medicine's tripartite mission.

Sincerely,

Paul B. Rothman, M.D.
Dean of the Medical Faculty
CEO, Johns Hopkins Medicine

Ronald R. Peterson
President
The Johns Hopkins Hospital and Health System
EVP, Johns Hopkins Medicine